Condition: Relapsing Multiple Sclerosis · Relapsing Remitting Multiple Sclerosis · Secondary Progressive Multiple Sclerosis · Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
This is a multi-center prospective rater-masked (blinded) randomized controlled trial of 156 participants, comparing the treatment strategy of Autologous Hematopoietic Stem Cell Transplantation (AHSCT) to the treatment strategy of Best Available Therapy (BAT) for treatment-resistant relapsing multiple sclerosis (MS). Participants will be randomized at a 1 to 1 (1:1) ratio. All participants will be followed for 72 months after randomization (Day 0, Visit 0).
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Stanford Multiple Sclerosis Center | Palo Alto, California, United States | Recruiting |
| Rocky Mountain Multiple Sclerosis Center, University of Colorado School of Medicine | Aurora, Colorado, United States | Recruiting |
| Northwestern University | Evanston, Illinois, United States | Recruiting |
| University of Massachusetts Memorial Medical Center | Worcester, Massachusetts, United States | Recruiting |
| University of Minnesota Multiple Sclerosis Center | Minneapolis, Minnesota, United States | Active Not Recruiting |
| Mayo Clinic | Rochester, Minnesota, United States | Recruiting |
| John L. Trotter Multiple Sclerosis Center, Washington University School of Medicine in St. Louis | St Louis, Missouri, United States | Recruiting |
| Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Siinai | New York, New York, United States | Recruiting |
| Rochester Multiple Sclerosis Center, University of Rochester | Rochester, New York, United States | Not Yet Recruiting |
| Duke University Medical Center | Durham, North Carolina, United States | Active Not Recruiting |
| University of Cincinnati (UC) Waddell Center for Multiple Sclerosis | Cincinnati, Ohio, United States | Recruiting |
| Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic | Cleveland, Ohio, United States | Recruiting |
+ 10 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04047628